ALBERTDAVD vs THEMISMED: Stock Comparison

Albert David Limited vs Themis Medicare Limited

Live data: 22 July 2026, 2:54 PM IST • Source: NSE and company filings

Themis Medicare Limited is the larger company by market capitalisation. Albert David Limited shows a lower P/E, a higher dividend yield and faster revenue growth, while Themis Medicare Limited shows a higher ROE, a higher ROCE and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Albert David Limited and Themis Medicare Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, ALBERTDAVD is more favourable on 7 of 13 scored metrics and THEMISMED on 5These counts are context-free and are not an overall rating.

Key Differences

Market Cap
THEMISMED is the larger company
₹1,004 Cr vs ₹391 Cr
P/E Ratio
ALBERTDAVD has a lower P/E
-264.18x vs 938.33x
P/B Ratio
ALBERTDAVD has a lower P/B
1.01x vs 2.6x
EPS
THEMISMED has higher earnings per share
₹0.12 vs ₹-2.65
Dividend Yield
ALBERTDAVD has a higher dividend yield
0.72% vs 0.43%
Revenue Growth (TTM YoY)
ALBERTDAVD has faster revenue growth
14.6% vs 6.7%
Qtr Sales Growth
ALBERTDAVD has stronger quarterly sales growth
14.6% vs 6.74%
Qtr Profit Growth
THEMISMED has stronger quarterly profit growth
192% vs -107%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricALBERTDAVDTHEMISMED
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricALBERTDAVDTHEMISMED
Live Price₹689.85₹108.06
Day Change-0.93%-3.82%
Volume1,44070,505
52-Week High₹922.95₹148
52-Week Low₹579.9₹64.95
Distance from 52W High-25.26%-26.99%

Valuation

MetricALBERTDAVDTHEMISMED
Market Cap₹391 Cr₹1,004 Cr
P/E Ratio-264.18x938.33x
P/B Ratio1.01x2.6x
EPS₹-2.65₹0.12
Book Value₹686.04₹43.06
Dividend Yield0.72%0.43%

Growth

MetricALBERTDAVDTHEMISMED
Revenue Growth (TTM YoY)14.6%6.7%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth14.6%6.74%
Qtr Profit Growth-107%192%

Profitability & Leverage

MetricALBERTDAVDTHEMISMED
ROE-0.38%0.29%
ROCE0.77%2.74%
Net Margin-0.45%0.33%
Operating Margin1.64%-2.9%
Debt to Equity0.08x25.11x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricALBERTDAVDTHEMISMED
Promoter Holding62.24%57.5%
FII Holding0.58% 0.02 pp0.11% 0.06 pp
DII Holding1.66%0.01%
Public Holding35.52% 0.02 pp32.78% 0.05 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Albert David Limited and Themis Medicare Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.